Parkinson's disease (PD) is a chronic and progressive neurodegenerative disease that affects dopamine-containing neurons of substantia nigra (SN) (
1). At the beginning of the disease course, pathologic changes in dopaminergic neurons lead to the loss of these neurons in SN, ventral tegmental area (VTA), and basal ganglia. In addition to movement disorders associated with dopamine in PD, there is an increasingly non-dopaminergic deficit in other known brain regions (
2-
4). Despite researching, diagnosing, and clinically managing PD for decades, inappropriate methods have restricted its diagnosis and prognosis. Because we cannot attain enough information using routine medical imaging techniques, diffusion tensor imaging (DTI) has been used as a kind of advanced medical imaging (ref).
Diffusion tensor imaging is a precise and non-invasive imaging technique to identify microstructural white matter (WM), gray matter abnormalities, and nerve fiber tracts’ changes to detect microstructural damage in PD (
5-
7). In the brain white matter, due to the presence of the myelin sheath, which serves as a barrier against water release, the water distribution is anisotropic in the nerve fiber bundles, and it is higher in the long axis of the bundles (
8). In a situation where the myelin of the axon structure is damaged, for example, by a stroke, brain tumors, or neurodegenerative diseases, like PD, the anisotropy is decreased, and the myelin sheath impermeability is affected by this injury (
8). In these cases, it is possible to obtain valuable information from the white matter condition by the data obtained from the distribution of water molecules and processing of these data (
9).